| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |